Dr. Catherine Ann Bonham, MD

Dr. Bonham practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Bonham's NPI, 1326248428, was assigned on July 18, 2007. Dr. Bonham graduated from University Of Michigan Medical School in 2007. Dr. Bonham holds Virginia license 0101266212.

Dr. Bonham's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Bonham's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Bonham is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Bonham to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonham practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Bonham's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Bonham is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bonham's licenses on file in 3 states: Virginia, Illinois and Michigan.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pleural effusion, pulmonary fibrosis, sleep apnea and tobacco use among the conditions Dr. Bonham treats.

CMS data shows 637 Medicare services from Dr. Bonham across 13 procedure codes in 2024, for 358 Medicare patients. Medicare paid $38,259 for them.

CMS counts 358 Medicare patients who saw Dr. Bonham in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bonham's median patient age at 60, with 56% women.

In 2024, Dr. Bonham wrote 358 Medicare Part D claims for 57 patients. 68% of them were for generic drugs. CMS names the drug for 249 of them, across 10 drugs with 11 or more claims each, at $249,040 in total drug cost. In 2023, CMS named 258 claims across 13 drugs.

Dr. Bonham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bonham as offering telehealth.

Dmand AI links 40 papers to Dr. Bonham, published from 2012 to 2024. 2024 was the busiest year, with 8. The most frequent topics are Sarcoidosis, Idiopathic Pulmonary Fibrosis and Lung. Dr. Bonham has published most often in Am J Respir Crit Care Med. Dr. Bonham's most frequent co-authors are Imre Noth, MD, Mary Strek and Alexandra Kadl, MD.

Dmand AI links Dr. Bonham to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Sarcoidosis, Pulmonary and Sarcoidosis.

CMS Open Payments shows 24 general payments to Dr. Bonham from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Abbvie Inc. paid the most, $2,613.

Dr. Bonham graduated from University Of Michigan Medical School in 2007.

Dr. Bonham is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.